vs
Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.
GSI TECHNOLOGY INC is the larger business by last-quarter revenue ($6.1M vs $5.4M, roughly 1.1× Tonix Pharmaceuticals Holding Corp.). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -870.3%, a 820.6% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 12.2%). GSI TECHNOLOGY INC produced more free cash flow last quarter ($-8.2M vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs 8.6%).
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
GSIT vs TNXP — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $5.4M |
| Net Profit | $-3.0M | $-46.9M |
| Gross Margin | 52.7% | 80.4% |
| Operating Margin | -113.7% | -895.8% |
| Net Margin | -49.7% | -870.3% |
| Revenue YoY | 12.2% | 108.8% |
| Net Profit YoY | 25.0% | -112.2% |
| EPS (diluted) | $-0.09 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $5.4M | ||
| Q3 25 | $6.4M | $3.3M | ||
| Q2 25 | $6.3M | $2.0M | ||
| Q1 25 | $5.9M | $2.4M | ||
| Q4 24 | $5.4M | $2.6M | ||
| Q3 24 | $4.5M | $2.8M | ||
| Q2 24 | $4.7M | $2.2M | ||
| Q1 24 | $5.2M | $2.5M |
| Q4 25 | $-3.0M | $-46.9M | ||
| Q3 25 | $-3.2M | $-32.0M | ||
| Q2 25 | $-2.2M | $-28.3M | ||
| Q1 25 | $-2.2M | $-16.8M | ||
| Q4 24 | $-4.0M | $-22.1M | ||
| Q3 24 | $-5.5M | $-14.2M | ||
| Q2 24 | $1.1M | $-78.8M | ||
| Q1 24 | $-4.3M | $-14.9M |
| Q4 25 | 52.7% | 80.4% | ||
| Q3 25 | 54.8% | 58.4% | ||
| Q2 25 | 58.1% | -63.8% | ||
| Q1 25 | 56.1% | 61.2% | ||
| Q4 24 | 54.0% | 54.2% | ||
| Q3 24 | 38.6% | 44.9% | ||
| Q2 24 | 46.3% | -52.5% | ||
| Q1 24 | 51.6% | 33.1% |
| Q4 25 | -113.7% | -895.8% | ||
| Q3 25 | -49.5% | -1005.1% | ||
| Q2 25 | -34.6% | -1416.2% | ||
| Q1 25 | -38.7% | -660.9% | ||
| Q4 24 | -74.9% | -870.6% | ||
| Q3 24 | -122.7% | -551.2% | ||
| Q2 24 | 23.1% | -3501.6% | ||
| Q1 24 | -87.6% | -860.2% |
| Q4 25 | -49.7% | -870.3% | ||
| Q3 25 | -49.4% | -972.9% | ||
| Q2 25 | -35.3% | -1415.0% | ||
| Q1 25 | -37.9% | -692.8% | ||
| Q4 24 | -74.4% | -856.2% | ||
| Q3 24 | -120.0% | -503.6% | ||
| Q2 24 | 23.1% | -3567.8% | ||
| Q1 24 | -83.9% | -601.9% |
| Q4 25 | $-0.09 | $-4.28 | ||
| Q3 25 | $-0.11 | $-3.59 | ||
| Q2 25 | $-0.08 | $-3.86 | ||
| Q1 25 | $-0.09 | $-2.84 | ||
| Q4 24 | $-0.16 | $2302.65 | ||
| Q3 24 | $-0.21 | $-22.68 | ||
| Q2 24 | $0.04 | $-1920.85 | ||
| Q1 24 | $-0.17 | $-535.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.7M | $207.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.6M | $245.2M |
| Total Assets | $98.5M | $277.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.7M | $207.6M | ||
| Q3 25 | $25.3M | $190.1M | ||
| Q2 25 | $22.7M | $125.3M | ||
| Q1 25 | $13.4M | $131.7M | ||
| Q4 24 | $15.1M | $98.8M | ||
| Q3 24 | $18.4M | $28.2M | ||
| Q2 24 | $21.8M | $4.2M | ||
| Q1 24 | $14.4M | $7.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.7M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $10.8M |
| Q4 25 | $83.6M | $245.2M | ||
| Q3 25 | $38.6M | $231.1M | ||
| Q2 25 | $37.4M | $168.0M | ||
| Q1 25 | $28.2M | $180.4M | ||
| Q4 24 | $29.9M | $139.6M | ||
| Q3 24 | $33.3M | $74.2M | ||
| Q2 24 | $38.0M | $42.1M | ||
| Q1 24 | $36.0M | $108.1M |
| Q4 25 | $98.5M | $277.2M | ||
| Q3 25 | $52.0M | $252.4M | ||
| Q2 25 | $50.5M | $187.4M | ||
| Q1 25 | $43.3M | $192.9M | ||
| Q4 24 | $44.1M | $162.9M | ||
| Q3 24 | $47.4M | $95.0M | ||
| Q2 24 | $52.3M | $70.3M | ||
| Q1 24 | $42.5M | $135.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.06× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $-39.6M |
| Free Cash FlowOCF − Capex | $-8.2M | $-41.5M |
| FCF MarginFCF / Revenue | -134.4% | -770.4% |
| Capex IntensityCapex / Revenue | 4.9% | 34.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $-103.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $-39.6M | ||
| Q3 25 | $-887.0K | $-28.8M | ||
| Q2 25 | $-1.7M | $-14.8M | ||
| Q1 25 | $-1.7M | $-16.6M | ||
| Q4 24 | $-3.6M | $-14.6M | ||
| Q3 24 | $-3.5M | $-18.8M | ||
| Q2 24 | $-4.3M | $-9.9M | ||
| Q1 24 | $-7.1M | $-17.6M |
| Q4 25 | $-8.2M | $-41.5M | ||
| Q3 25 | $-906.0K | $-29.7M | ||
| Q2 25 | $-1.7M | $-15.4M | ||
| Q1 25 | $-1.7M | $-16.6M | ||
| Q4 24 | $-3.6M | $-14.6M | ||
| Q3 24 | $-3.5M | $-18.8M | ||
| Q2 24 | $-4.3M | — | ||
| Q1 24 | $-7.2M | $-17.7M |
| Q4 25 | -134.4% | -770.4% | ||
| Q3 25 | -14.1% | -904.1% | ||
| Q2 25 | -27.6% | -768.8% | ||
| Q1 25 | -28.3% | -682.8% | ||
| Q4 24 | -66.1% | -566.7% | ||
| Q3 24 | -76.6% | -666.5% | ||
| Q2 24 | -92.0% | — | ||
| Q1 24 | -139.0% | -712.4% |
| Q4 25 | 4.9% | 34.8% | ||
| Q3 25 | 0.3% | 29.2% | ||
| Q2 25 | 0.3% | 26.4% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.2% | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.96× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
